What your processor needs before they will approve you
High-risk underwriting is not a credit check. It is a file review, and the file either answers an underwriter's questions or it does not.
Most declines in this category are not judgments about whether the business is legitimate. They are the result of an incomplete application that made a busy person guess, and guessing in a category with FDA enforcement history resolves against you. The good news is that this is a preparation problem, which means it is solvable before you apply rather than appealed afterward.
Here is what goes in the file.
Corporate and identity
Verified first, and cross-checked against each other. A mismatch between any two of these is one of the most common reasons a file stalls.
- Articles of incorporation or LLC certificate, entity in good standing
- IRS EIN confirmation letter, legal name matching the entity exactly
- Government photo ID for every principal owning 25% or more
- Proof of residential address for those principals
- Business bank account in the same legal name, at the same address
Underwriters compare the entity name on the formation document against the bank record, the website footer, and the application. A typo reads as a discrepancy, not as a typo, and it is the cheapest possible reason to get declined.
Financial history
- Three months of business bank statements
- Three months of prior processing statements, if you have any history
If you were previously terminated, do not omit that history and hope it goes unnoticed. Acquirers query shared databases during underwriting. Disclosing a prior termination with an explanation of what changed is survivable; being caught concealing it is not, and it converts a difficult application into a closed door.
The documents specific to this category
This is where generic payments advice stops being useful, and where peptide applications are actually decided.
- Third-party certificates of analysis with assay data, purity, and molecular weight
- High-resolution images of your actual product labels, not mockups
- Written standard operating procedures for storage and handling
- Live website screenshots including the checkout flow
- Terms of service, privacy policy, and refund, return, shipping, and cancellation policies
- A written chargeback mitigation plan
The chargeback plan is the one most founders skip, and it is the one that most changes an underwriter's read. It is evidence that you understand the risk they are being asked to take. A specific one-page plan naming your descriptor, your refund window, your support response time, and the dispute-deflection networks you have enrolled in outperforms a generic template by a wide margin.
Product labels matter for a related reason: the underwriter is checking whether what is printed on the vial agrees with what the website says. Any drift between the two is the exact discrepancy the file review exists to catch.
What they check on your site
Someone will open your storefront. Assume it happens, and assume they read like a regulator rather than a customer.
- Research-use-only positioning, stated consistently rather than buried in a footer
- “Not for human consumption” labeling on products and product pages
- Age verification before purchase
- Restricted-jurisdiction blocking enforced at checkout, not merely described in a policy
- A certificate of analysis reachable from every product
- Accurate pricing, with no medical, therapeutic, dosing, or human-use claims anywhere
- Working contact information and support that answers
- A per-order audit trail recording the research-use acknowledgment with a timestamp
“Anywhere” includes your blog, your email, and your product descriptions. Enforcement in this category is judged against the totality of how you market, so a single claim on a single page can undo an otherwise clean file.
What to expect once you are approved
Approval comes with terms, and those terms are part of the deal rather than a surprise afterward:
- A rolling reserve, commonly 5% to 15% of daily batches held 90 to 180 days
- A discount rate well above standard retail, commonly in the 3.5% to 5% range for established accounts and higher for new ones
- Per-authorization fees, chargeback fees per dispute, and possibly a setup fee
Rates and reserves both tend to improve with roughly six months of clean processing history, and both are renegotiable. Almost nobody asks.
Do this before you apply, not during
Underwriting is faster and lands better when the file arrives complete. A sequence that works:
- Form the entity, get the EIN, open the business bank account, and confirm all three names match exactly.
- Get the storefront to the standard above and leave it there. Do not clean it up for the application and drift afterward, because the review that matters most is the one that happens later.
- Assemble COAs, label images, and SOPs into one folder.
- Write the chargeback plan. One page.
- Apply to two acquirers, not one. Approval takes weeks, and you want the second account underwritten before you need it rather than after.
The mental shift that helps is this: getting approved is a documentation exercise, and staying approved is a function of what your site says every day afterward. Both are within your control, which is more than most operators in this category assume.
The whole checklist in one page
Everything above, plus the 2026 dispute thresholds and the questions to put to your acquirer, formatted to work through before you apply.
Get the Payment-Approval Checklist (PDF) →Keep reading
→ The five-element COA every research buyer checks → Cold chain for lyophilized peptides: moisture, not heat → Lot traceability: answering "who received Lot X?" in minutes → What a state-restriction block page should actually say → What a rolling reserve is, and how to get yours back → The MATCH list is a five-year sentence → Why Stripe shut you down (and why it will happen again) → Research-use-only compliance basicsThis guide is general information, not legal, financial, or payments advice. Documentation requirements, rates, and reserve terms vary by acquirer and change over time; the ranges described are commonly reported market terms rather than published rules. Confirm requirements with your processor and consult qualified professionals.